Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annie Mayence

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Pharmaceuticals (Basel, Switzerland)|February 2, 2017
Second International Electronic Conference on Medicinal Chemistry (ECMC-2)Annie Mayence, Jean Jacques Vanden Eynde
Pharmaceuticals (Basel, Switzerland)|March 16, 2019
Baricitinib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Janus KinasesAnnie Mayence, Jean Jacques Vanden Eynde
Pharmaceuticals (Basel, Switzerland)|August 2, 2019
Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of <i>Plasmodium vivax</i> Malaria and Prophylaxis of MalariaAnnie Mayence, Jean Jacques Vanden Eynde
Pharmaceuticals (Basel, Switzerland)|February 10, 2018
Third International Electronic Conference on Medicinal Chemistry (ECMC-3)Annie Mayence, Jean Jacques Vanden Eynde
Bioorganic & Medicinal Chemistry|March 18, 2014
Some non-conventional biomolecular targets for diamidines. A short surveyTien L Huang, Annie Mayence, Jean Jacques Vanden Eynde
Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Evidences for the formation of bisbenzamidine-heme complexes in cell-free systemsAnnie Mayence, Jean Jacques Vanden Eynde, Tien L Huang
Molecules (Basel, Switzerland)|September 17, 2013
Design and synthesis of N¹,N⁵-bis[4-(5-alkyl-1,2,4-oxadiazol-3-yl)phenyl]glutaramides as potential antifungal prodrugsNageswara Rao Kode, Jean J Vanden Eynde, Annie Mayence, et al.
Bioorganic & Medicinal Chemistry|November 9, 2011
Bis(oxyphenylene)benzimidazoles: a novel class of anti-Plasmodium falciparum agentsAnnie Mayence, Jean Jacques Vanden Eynde, Marcel Kaiser, et al.
European Journal of Medicinal Chemistry|June 9, 2004
Piperazine-linked bisbenzamidines: a novel class of antileishmanial agentsAnnie Mayence, Jean Jacques Vanden Eynde, Louis LeCour, et al.
The Journal of Pharmacy and Pharmacology|July 29, 2006
Anti-plasmodial and anti-leishmanial activity of conformationally restricted pentamidine congenersTien L Huang, Jean Jacques Vanden Eynde, Annie Mayence, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Pharmaceuticals (Basel, Switzerland)|February 2, 2017
Second International Electronic Conference on Medicinal Chemistry (ECMC-2)Annie Mayence, Jean Jacques Vanden Eynde
Pharmaceuticals (Basel, Switzerland)|March 16, 2019
Baricitinib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Janus KinasesAnnie Mayence, Jean Jacques Vanden Eynde
Pharmaceuticals (Basel, Switzerland)|August 2, 2019
Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of <i>Plasmodium vivax</i> Malaria and Prophylaxis of MalariaAnnie Mayence, Jean Jacques Vanden Eynde
Pharmaceuticals (Basel, Switzerland)|February 10, 2018
Third International Electronic Conference on Medicinal Chemistry (ECMC-3)Annie Mayence, Jean Jacques Vanden Eynde
Bioorganic & Medicinal Chemistry|March 18, 2014
Some non-conventional biomolecular targets for diamidines. A short surveyTien L Huang, Annie Mayence, Jean Jacques Vanden Eynde
Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Evidences for the formation of bisbenzamidine-heme complexes in cell-free systemsAnnie Mayence, Jean Jacques Vanden Eynde, Tien L Huang
Molecules (Basel, Switzerland)|September 17, 2013
Design and synthesis of N¹,N⁵-bis[4-(5-alkyl-1,2,4-oxadiazol-3-yl)phenyl]glutaramides as potential antifungal prodrugsNageswara Rao Kode, Jean J Vanden Eynde, Annie Mayence, et al.
Bioorganic & Medicinal Chemistry|November 9, 2011
Bis(oxyphenylene)benzimidazoles: a novel class of anti-Plasmodium falciparum agentsAnnie Mayence, Jean Jacques Vanden Eynde, Marcel Kaiser, et al.
European Journal of Medicinal Chemistry|June 9, 2004
Piperazine-linked bisbenzamidines: a novel class of antileishmanial agentsAnnie Mayence, Jean Jacques Vanden Eynde, Louis LeCour, et al.
The Journal of Pharmacy and Pharmacology|July 29, 2006
Anti-plasmodial and anti-leishmanial activity of conformationally restricted pentamidine congenersTien L Huang, Jean Jacques Vanden Eynde, Annie Mayence, et al.
Pageof 3